Literature DB >> 19588543

Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.

Anurupa Chakraborty1, Ashwani K Mishra, Abha Soni, Thodum Regina, R Mohil, D Bhatnagar, A Bhatnagar, Chintamani Chintamani, P C Sharma, Sunita Saxena.   

Abstract

BACKGROUND: Vitamin D (1,25-dihydroxyVitamin D3) has shown experimentally anticarcinogenic effects and is thought to protect against breast cancer. The actions of Vitamin D are mediated via the Vitamin D receptor (VDR), and the polymorphisms at 3'UTR region of this gene are associated with the risk and progression of breast carcinoma. The current study is an attempt to examine the association of these variations with breast cancer risk in north Indians.
METHODS: A total of 160 cases and 140 control subjects were studied for the polymorphisms at 3' end of the VDR gene. A polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) method and fragment analysis was performed to determine ApaI and TaqI polymorphisms and variable length poly-A microsatellite repeats. Linkage disequilibrium (LD) was calculated for each pair of polymorphisms. Unadjusted and adjusted odds ratios for breast cancer with genotypes comprising the polymorphic sites were calculated to understand their role towards breast cancer susceptibility.
RESULTS: Patient's with long poly-A repeat showed a significant association with disease (chi 2 = 9.52, df = 2, P <or= 0.01). Compared to subjects having two S alleles (SS), odds ratios (and 95% CI) were 0.75 (0.45-1.23) and 2.49 (1.18-5.27) for subjects having genotypes SL and LL, respectively. Among matched pairs (age), the poly-A LL genotype was found significantly associated with increased risk of breast cancer among early-onset cases (P = 0.02). The unconditional logistic regression analysis demonstrated a significant association between grade and LL genotype [(unadjusted odds ratio (95% CI): 4.45 (1.87, 10.63); adjusted odds ratio: 4.66 (1.88, 11.53)]. No significant association was observed for the VDR ApaI (chi 2 = 1.00, df = 2, P = 0.60) and TaqI polymorphism (chi 2 = 0.35, df = 2, P = 0.83). Although, strong LD was not observed among these polymorphic sites, it denies the total equilibrium at the same time. Based on haplotype distribution, the most common one observed among cases and controls was ATS while, genotype AATTLL had shown a significant association with the breast cancer risk (P = 0.02).
CONCLUSIONS: The results indicate that the VDR poly-A polymorphism is significantly associated with breast cancer risk in north Indians especially with early onset disease. Although, ApaI and TaqI did not show any significant association with the disease when analyzed in isolation, but TaqI might modulate the risk associated with L alleles. Further, understanding the functional role of these variants residing on the VDR haplotype associated with disease susceptibility may suggest novel approaches for breast cancer prevention and therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19588543     DOI: 10.1016/j.canep.2009.04.012

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  16 in total

1.  Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population.

Authors:  Wani Arjumand; Shiekh Tanveer Ahmad; Amlesh Seth; Ashish Kumar Saini; Sarwat Sultana
Journal:  Tumour Biol       Date:  2011-09-20

2.  TaqI polymorphism of VDR gene contributes to breast cancer risk.

Authors:  Hua Wang; Wenjian Wang; Dongjie Yang; Shenming Wang
Journal:  Tumour Biol       Date:  2013-08-01

3.  Associations between vitamin D receptor polymorphisms and breast cancer risk.

Authors:  Jie Wang; Qi He; Yu-Guo Shao; Min Ji; Wei Bao
Journal:  Tumour Biol       Date:  2013-07-31

4.  Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.

Authors:  Laura L Reimers; Katherine D Crew; Patrick T Bradshaw; Regina M Santella; Susan E Steck; Iryna Sirosh; Mary Beth Terry; Dawn L Hershman; Elizabeth Shane; Serge Cremers; Elzbieta Dworakowski; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon
Journal:  Cancer Causes Control       Date:  2014-11-25       Impact factor: 2.506

5.  Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis.

Authors:  Shayang Luo; Lei Guo; Yan Li; Shouman Wang
Journal:  Tumour Biol       Date:  2013-09-19

6.  Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.--a SEER analysis.

Authors:  Madhuri Kakarala; Laura Rozek; Michele Cote; Samadhi Liyanage; Dean E Brenner
Journal:  BMC Cancer       Date:  2010-05-11       Impact factor: 4.430

7.  Association between vitamin D receptor gene polymorphisms and breast cancer in a Chinese population.

Authors:  Bingjun Guo; Xin Jiang; Xiaoqiao Hu; Fan Li; Xiaopin Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  Genetic epidemiology of osteoporosis across four microsatellite markers near the VDR gene.

Authors:  Mehrunnisa Raje; Chaitali Botre; Richa Ashma
Journal:  Int J Mol Epidemiol Genet       Date:  2013-06-25

9.  Association between vitamin D receptor poly(A) polymorphism and breast cancer risk: a meta-analysis.

Authors:  Jinjiang Xu; Hongyu Li; Lixue Gu; Xiaoping Zhou
Journal:  Tumour Biol       Date:  2013-09-15

10.  The association between the poly(A) polymorphism in the VDR gene and cancer risk: a meta-analysis.

Authors:  Jin Huang; Jiqiao Yang; Haichuan Wang; Tianyuan Xiong; Hongbo Zhang; Yaxian Ma; Xiaoze Wang; Jichong Huang; Liang Du
Journal:  Tumour Biol       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.